Compile Data Set for Download or QSAR
maximum 50k data
Found 826 with Last Name = 'milton' and Initial = 'j'
TargetAldo-keto reductase family 1 member C2(Homo sapiens (Human))
University Of Auckland

Curated by ChEMBL
LigandPNGBDBM50396691(CHEMBL449572 | US9271961, Jasmonic acid)
Affinity DataKi:  1.80E+4nMAssay Description:Inhibition of human recombinant AKR1C2 expressed in Escherichia coli BL21(DE3) using phenanthrenequinone as substrate by spectrophotometric analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAldo-keto reductase family 1 member C4(Homo sapiens (Human))
University Of Auckland

Curated by ChEMBL
LigandPNGBDBM50396691(CHEMBL449572 | US9271961, Jasmonic acid)
Affinity DataKi:  3.70E+4nMAssay Description:Inhibition of human recombinant AKR1C4 expressed in Escherichia coli BL21(DE3) using phenanthrenequinone as substrate by spectrophotometric analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAldo-keto reductase family 1 member C1(Homo sapiens (Human))
University Of Auckland

Curated by ChEMBL
LigandPNGBDBM50396691(CHEMBL449572 | US9271961, Jasmonic acid)
Affinity DataKi:  1.06E+5nMAssay Description:Inhibition of human recombinant AKR1C1 expressed in Escherichia coli BL21(DE3) using phenanthrenequinone as substrate by spectrophotometric analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAldo-keto reductase family 1 member C3(Homo sapiens (Human))
University Of Auckland

Curated by ChEMBL
LigandPNGBDBM50396691(CHEMBL449572 | US9271961, Jasmonic acid)
Affinity DataKi:  1.62E+5nMAssay Description:Inhibition of human recombinant AKR1C3 expressed in Escherichia coli BL21(DE3) using phenanthrenequinone as substrate by spectrophotometric analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652305(US20240059675, Example 8)
Affinity DataIC50: <1nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652305(US20240059675, Example 8)
Affinity DataIC50:  1nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652310(US20240059675, Example 13)
Affinity DataIC50:  1nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652310(US20240059675, Example 13)
Affinity DataIC50:  1nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652312(US20240059675, Example 15)
Affinity DataIC50:  1nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652312(US20240059675, Example 15)
Affinity DataIC50:  1nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652313(US20240059675, Example 16)
Affinity DataIC50:  1nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652318(US20240059675, Example 21)
Affinity DataIC50:  1nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652324(US20240059675, Example 26)
Affinity DataIC50:  1nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652324(US20240059675, Example 26)
Affinity DataIC50:  1nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652363(US20240059675, Example 32)
Affinity DataIC50:  1nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652363(US20240059675, Example 32)
Affinity DataIC50:  1nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652300(US20240059675, Example 4)
Affinity DataIC50:  1nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Homo sapiens (Human))
Curtin University

Curated by ChEMBL
LigandPNGBDBM50121212(CHEMBL3622372)
Affinity DataIC50:  1.20nMAssay Description:Inhibition of Vps34 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652304(US20240059675, Example 7)
Affinity DataIC50:  2nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652309(US20240059675, Example 12)
Affinity DataIC50:  2nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652309(US20240059675, Example 12)
Affinity DataIC50:  2nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652316(US20240059675, Example 19)
Affinity DataIC50:  2nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652326(US20240059675, Example 28)
Affinity DataIC50:  2nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652327(US20240059675, Example 29)
Affinity DataIC50:  2nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652328(US20240059675, Example 30)
Affinity DataIC50:  2nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652328(US20240059675, Example 30)
Affinity DataIC50:  2nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652330(US20240059675, Example 31)
Affinity DataIC50:  2nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetDNA-dependent protein kinase catalytic subunit(Homo sapiens (Human))
Curtin University

Curated by ChEMBL
LigandPNGBDBM50197065(CHEMBL3913354)
Affinity DataIC50:  2nMAssay Description:Inhibition of DNA-PK (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDNA-dependent protein kinase catalytic subunit(Homo sapiens (Human))
Curtin University

Curated by ChEMBL
LigandPNGBDBM50261349(CHEMBL4073785)
Affinity DataIC50:  2nMAssay Description:Inhibition of DNA-PK in human HeLa nuclear extracts incubated for 40 mins using calf thymus DNA and fluoroscein-p53[Ser15]-peptide by Lanthascreen ti...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDNA-dependent protein kinase catalytic subunit(Homo sapiens (Human))
Curtin University

Curated by ChEMBL
LigandPNGBDBM50261349(CHEMBL4073785)
Affinity DataIC50:  2nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652297(US20240059675, Example 1)
Affinity DataIC50:  2nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652298(US20240059675, Example 2)
Affinity DataIC50:  2nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652299(US20240059675, Example 3)
Affinity DataIC50:  2nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652299(US20240059675, Example 3)
Affinity DataIC50:  2nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652301(US20240059675, Example 5)
Affinity DataIC50:  2nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652303(US20240059675, Example 6)
Affinity DataIC50:  2nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Curtin University

Curated by ChEMBL
LigandPNGBDBM92862(US9284315, BEZ-235 | mTOR Inhibitor, BEZ235)
Affinity DataIC50:  2nMAssay Description:Inhibition of human recombinant mTOR using substrate PI incubated for 1 hr by Adapta kinase assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase mTOR(Homo sapiens (Human))
Curtin University

Curated by ChEMBL
LigandPNGBDBM50042923(CHEMBL3354566)
Affinity DataIC50:  2nMAssay Description:Inhibition of human mTOR by non-radiometric ADP-Glo assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDNA-dependent protein kinase catalytic subunit(Homo sapiens (Human))
Curtin University

Curated by ChEMBL
LigandPNGBDBM25045(3-(4-morpholin-4-ylpyrido[2,3]furo[2,4-b]pyrimidin...)
Affinity DataIC50:  2nMAssay Description:Inhibition of human DNA-PK by non-radiometric ADP-Glo assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutaminyl-peptide cyclotransferase(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652318(US20240059675, Example 21)
Affinity DataIC50:  3nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652319(US20240059675, Example 22)
Affinity DataIC50:  3nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652325(US20240059675, Example 27)
Affinity DataIC50:  3nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652326(US20240059675, Example 28)
Affinity DataIC50:  3nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652327(US20240059675, Example 29)
Affinity DataIC50:  3nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652330(US20240059675, Example 31)
Affinity DataIC50:  3nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetHistone deacetylase 1(Homo sapiens (Human))
China Pharmaceutical University

Curated by ChEMBL
LigandPNGBDBM50123628(CHEMBL3622730)
Affinity DataIC50:  3.10nMAssay Description:Inhibition of recombinant human C-terminal FLAG/His-tagged HDAC1 (1 to 482 residues) expressed in Sf9 insect cells using fluorometric substrate measu...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652306(US20240059675, Example 9)
Affinity DataIC50:  4nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652307(US20240059675, Example 10)
Affinity DataIC50:  4nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652313(US20240059675, Example 16)
Affinity DataIC50:  4nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetGlutaminyl-peptide cyclotransferase-like protein(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM652314(US20240059675, Example 17)
Affinity DataIC50:  4nMAssay Description:QPCT or QPCTL dependent conversion of N-terminal glutamine to pyroglutamate of CD47 was monitored via MALDI-TOF MS. Test compounds were dissolved in ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
Displayed 1 to 50 (of 826 total ) | Next | Last >>
Jump to: